Diabetes Research

Trial Watch: VX-264 For Type 1 Diabetes Discontinued

Vertex Continues Multiple Paths To Potential Islet Cell Cure

Fully Closed AID systems Effective Without Meal Announcements

Diabetes Technology Highlights from ATTD 2025

Afrezza Inhaled Insulin for Type 1 and Type 2 Diabetes

New Weight Loss Drug CagriSema Shows Impressive Results in Clinical Trials
Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.